HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kim Selected Research

Human papillomavirus type 16 E6 protein

1/2007Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Kim Research Topics

Disease

68Neoplasms (Cancer)
01/2022 - 01/2000
25Infections
11/2020 - 09/2000
16Inflammation (Inflammations)
01/2020 - 01/2000
15Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2003
12Neoplasm Metastasis (Metastasis)
01/2022 - 03/2000
11Breast Neoplasms (Breast Cancer)
05/2019 - 06/2001
11Alzheimer Disease (Alzheimer's Disease)
05/2016 - 01/2001
8Colonic Neoplasms (Colon Cancer)
04/2008 - 07/2000
7Hepatocellular Carcinoma (Hepatoma)
01/2020 - 02/2001
7Carcinoma (Carcinomatosis)
01/2018 - 07/2001
7Myocardial Infarction
12/2005 - 01/2000
6Thyroid Neoplasms (Thyroid Cancer)
05/2021 - 05/2005
6Pain (Aches)
03/2021 - 03/2001
6Hypertension (High Blood Pressure)
08/2020 - 03/2000
6Adenocarcinoma
09/2019 - 01/2001
6Squamous Cell Carcinoma of Head and Neck
01/2019 - 02/2010
6Disease Progression
01/2018 - 05/2000
6Asthma (Bronchial Asthma)
01/2018 - 09/2000
6Obesity
01/2018 - 12/2000
6Leukemia
04/2015 - 07/2000
6Chronic Kidney Failure (Chronic Renal Failure)
07/2014 - 11/2000
6Carcinogenesis
11/2013 - 02/2000
6Necrosis
08/2009 - 01/2000
6IGA Glomerulonephritis (IGA Nephropathy)
08/2008 - 02/2001
5Body Weight (Weight, Body)
10/2018 - 09/2000
5Cognitive Dysfunction
01/2018 - 08/2006
5Stroke (Strokes)
10/2017 - 03/2000
5Experimental Arthritis
06/2017 - 01/2000
5Sepsis (Septicemia)
05/2017 - 04/2001
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2015 - 03/2000
5Type 2 Diabetes Mellitus (MODY)
08/2014 - 01/2000
5Vascular Diseases (Vascular Disease)
12/2010 - 03/2000
5Arthritis (Polyarthritis)
07/2008 - 01/2000
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2007 - 04/2001
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 02/2001
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2012
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 03/2000
4Periodontitis
01/2020 - 02/2016
4Mental Disorders (Mental Disorder)
07/2019 - 03/2010
4Insulin Resistance
01/2019 - 03/2013
4Hemorrhage
10/2018 - 04/2007
4Fibrosis (Cirrhosis)
11/2017 - 01/2003
4Prostatic Neoplasms (Prostate Cancer)
03/2016 - 01/2001
4Lupus Nephritis
01/2016 - 01/2000
4Hyperplasia
01/2016 - 05/2001
4Renal Cell Carcinoma (Grawitz Tumor)
06/2014 - 10/2000
4Atrophy
07/2013 - 03/2002
4Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2012 - 05/2001
4Burns
01/2012 - 07/2000

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2000
24CytokinesIBA
06/2022 - 09/2000
15Messenger RNA (mRNA)IBA
10/2018 - 02/2000
11Biomarkers (Surrogate Marker)IBA
07/2019 - 07/2001
11LigandsIBA
08/2009 - 04/2000
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 04/2001
10DNA (Deoxyribonucleic Acid)IBA
12/2017 - 01/2000
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 01/2000
8Pharmaceutical PreparationsIBA
09/2022 - 01/2000
8NF-kappa B (NF-kB)IBA
10/2018 - 07/2000
8Biological ProductsIBA
11/2016 - 04/2001
7ErbB Receptors (EGF Receptor)IBA
12/2016 - 12/2000
7RNA (Ribonucleic Acid)IBA
03/2016 - 05/2000
7Axitinib (AG 013736)IBA
12/2014 - 10/2009
7Complementary DNA (cDNA)IBA
12/2010 - 09/2000
6Oxygen (Dioxygen)IBA
01/2019 - 06/2000
6Angiotensin IIIBA
08/2005 - 03/2000
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 01/2018
5Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 12/2001
5EnzymesIBA
10/2019 - 12/2001
5Glucose (Dextrose)FDA LinkGeneric
01/2019 - 09/2000
5Therapeutic UsesIBA
10/2018 - 03/2001
5Amyloid (Amyloid Fibrils)IBA
01/2018 - 02/2001
5Estrogen ReceptorsIBA
01/2017 - 08/2002
5Cisplatin (Platino)FDA LinkGeneric
01/2017 - 03/2005
5AntigensIBA
07/2008 - 03/2000
5Interleukin-4 (Interleukin 4)IBA
06/2007 - 01/2000
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2005 - 10/2000
4CreatinineIBA
01/2020 - 04/2001
4Fluorouracil (Carac)FDA LinkGeneric
09/2019 - 12/2013
4Insulin (Novolin)FDA Link
01/2019 - 11/2002
4Cetuximab (Erbitux)FDA Link
01/2018 - 11/2011
4Interleukin-6 (Interleukin 6)IBA
06/2017 - 01/2003
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2017 - 12/2000
4AlbuminsIBA
04/2016 - 08/2001
4Interleukin-12 (IL 12)IBA
01/2016 - 03/2000
4Bevacizumab (Avastin)FDA Link
01/2016 - 02/2010
4Etoposide (VP 16)FDA LinkGeneric
09/2012 - 04/2001
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2011 - 07/2000
4Phosphotransferases (Kinase)IBA
08/2011 - 10/2000

Therapy/Procedure

56Therapeutics
12/2020 - 03/2000
17Drug Therapy (Chemotherapy)
01/2022 - 09/2000
10Radiotherapy
04/2020 - 06/2000
8Gastrectomy
11/2015 - 07/2004
7Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2005 - 01/2000
6Ligation
01/2020 - 01/2000
6Transplantation
06/2015 - 04/2000
5Neoadjuvant Therapy
05/2020 - 02/2010
5Renal Dialysis (Hemodialysis)
07/2014 - 04/2001
4Chemoradiotherapy
01/2021 - 09/2003
4Stem Cell Transplantation
06/2015 - 09/2009